Drug · DIN 02436876
CELECOXIB
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 24, 2023.
- Drug Identification Number (DIN)
- 02436876
- Company (DIN owner)
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Celecoxib M01AH01
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CELECOXIB | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 24, 2015: NOC 16636Abbreviated New Drug Submission (ANDS) · Additional product name
Other DINs named CELECOXIB
- DIN 02424371 · Marketed
- DIN 02424398 · Marketed
- DIN 02429675 · Marketed
- DIN 02429683 · Marketed
- DIN 02436299 · Marketed
- DIN 02436302 · Marketed
- DIN 02384299 · Cancelled Pre Market
- DIN 02384302 · Cancelled Pre Market
- DIN 02413019 · Approved
- DIN 02413027 · Approved
- DIN 02436868 · Cancelled Pre Market
- DIN 02477661 · Cancelled Post Market
- DIN 02477688 · Cancelled Post Market